Drug pricing policy and its impact on clinical practice

Drug pricing policy increasingly shapes clinical practice in ways that directly affect patient care, adherence, and outcomes. Nurse practitioners frequently encounter situations where clinically appropriate medications are unaffordable for patients, requiring navigation of formularies, prior authorizations, and cost-saving tools. This editorial explores how pharmacy benefit managers (PBMs) and vertically integrated health care organizations influence medication access and pricing structures within the US health care system. Although PBMs were originally designed to reduce costs and improve efficiency, their evolving role as intermediaries has contributed to complex pricing mechanisms that often obscure true medication costs. Recent federal PBM reforms aim to increase transparency and address rising drug expenditures; however, ongoing market consolidation continues to shift financial strategies within health care systems. As a result, prescribing decisions are increasingly shaped by policy and market forces rather than clinical evidence alone. Nurse practitioners are positioned at the intersection of these dynamics and must integrate cost awareness, patient-centered communication, and advocacy into clinical practice.